Navigation Links
Schering-Plough CEO Calls for Four-Pronged Approach to Improving Current Health Care Environment

ORLANDO, Fla., Nov. 2 /PRNewswire-FirstCall/ -- Addressing more than 100 cardiologists and other medical experts from 24 countries, Fred Hassan, Schering-Plough chairman and CEO, set out four critical priorities for improving the current health care environment. Hassan spoke today at Schering-Plough's fourth annual Cardiovascular Summit in advance of the American Heart Association's annual Scientific Sessions 2007.

In his speech, Hassan emphasized the potential for innovations to achieve major medical progress and improved treatment outcomes. He pointed to a study published in The New England Journal of Medicine (June 7, 2007 issue) that explored the reasons behind a dramatic decrease in U.S. deaths from cardiovascular disease between 1980-2000.

Hassan also reviewed the progress of Schering-Plough's transformation, its continuing investment in R&D and the promise of its planned combination with Organon BioSciences N.V.

Addressing the broader health care environment, Hassan identified four critical areas of opportunity for improvement:

-- First, transform the quality of care;

-- Second, transform biopharma's innovation engines;

-- Third, support a strong U.S. Food and Drug Administration; and,

-- Fourth, improve access and affordability for patients.

Hassan's speech (as prepared for delivery) is available via the following link:

Schering-Plough is a global science-based health care company with leading prescription, consumer and animal health products. Through internal research and collaborations with partners, Schering-Plough discovers, develops, manufactures and markets advanced drug therapies to meet important medical needs. Schering-Plough's vision is to earn the trust of the physicians, patients and customers served by its approximately 33,500 people around the world. The company is based in Kenilworth, N.J., and its Web site is

SOURCE Schering-Plough
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Asmanex Twisthaler launched by Schering-Plough for treatment of asthma
2. Calls to combat deafness after chemotherapy
3. WHO Calls For Greater Emphasis On Combating AIDS
4. PCT Calls Upon Doctor To Delay Surgeries
5. UN Calls For More Funds For Earthquake Affected
6. MP Calls For Ban On Aspartame
7. Scientist Calls Upon Media To Retract His Work
8. CMHA Calls For Better Trained Police For Dealing With The Mentally Ill
9. US Government Calls For Better Drug Supplies
10. Phone Calls Lend Vital Support to Moms of Mentally Ill Children
11. Report Calls For Better Implementation Of Last Wishes of Terminally Ill
Post Your Comments:
(Date:11/25/2015)... ... ... “While riding the bus, I saw a passenger in a wheelchair drenched from ... a convenient and comfortable way to protect them from bad weather, so I invented ... during cold or inclement weather. In doing so, it ensures that the user remains ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups responsible for advancing care ... disease. The Periwinkle Pioneers, nominated by the public, will receive special recognition throughout ...
(Date:11/25/2015)... ... November 25, 2015 , ... An unlikely combination ... in a way for homeless people to have a more dignified and comfortable ... initiative whereby they are repurposing plastic bags into sleeping mats for the homeless. ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... focused on providing comprehensive solutions involving adult stem cell therapies to patients with ... deemed the “Regenestem” name as a Registered Trademark (RTM). , Organizations are required ...
(Date:11/24/2015)... ... 2015 , ... Genesis Chiropractic Software helps practice owners automate ... between the practice owner and the patient that automatically manages all five aspects ... Click here to learn more. , According to Dr. Brian ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... , November 25, 2015 Kitov ... ) (TASE: KTOV), a biopharmaceutical company focused on the ... various clinical conditions, today announced the closing of its ... Shares ( ADSs ), each representing 20 ordinary shares ... 3,158,900 ADSs. The ADSs and warrants were issued in ...
(Date:11/25/2015)... , Nov. 25, 2015 Allergan ... pharmaceutical company, and Rugen Therapeutics, a start-up  biotechnology ... for unmet CNS disorders and funded by the ... they have entered into an exclusive collaboration to ... for Autism Spectrum Disorders (ASD) and Obsessive Compulsive ...
(Date:11/25/2015)... Israel , November 25, 2015 ... "New Investors"), pursuant to which BioLight and the New ... IOPtima Ltd. subsidiary ("IOPtima") via a private placement. The ... of its innovative IOPtimate™ system used in the treatment ... approval pathway process for the IOPtimate™ system with the ...
Breaking Medicine Technology: